Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $2.0 million.

  • Tg Therapeutics' Other Non-Current Assets fell 326.4% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 326.4%. This contributed to the annual value of $2.1 million for FY2024, which is 1017.76% down from last year.
  • Per Tg Therapeutics' latest filing, its Other Non-Current Assets stood at $2.0 million for Q3 2025, which was down 326.4% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Other Non-Current Assets peaked at $2.3 million during Q4 2023, and registered a low of $1.3 million during Q1 2021.
  • In the last 5 years, Tg Therapeutics' Other Non-Current Assets had a median value of $1.3 million in 2023 and averaged $1.6 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 8138.26% in 2023, then plummeted by 1017.76% in 2024.
  • Quarter analysis of 5 years shows Tg Therapeutics' Other Non-Current Assets stood at $1.3 million in 2021, then increased by 0.71% to $1.3 million in 2022, then skyrocketed by 81.38% to $2.3 million in 2023, then decreased by 10.18% to $2.1 million in 2024, then decreased by 1.4% to $2.0 million in 2025.
  • Its Other Non-Current Assets was $2.0 million in Q3 2025, compared to $2.0 million in Q2 2025 and $2.0 million in Q1 2025.